Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia
NCT00117546 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2010-06-08
Summary
A history of preeclampsia is associated with a low plasma volume and higher sympathetic activity. Methyldopa will suppress sympathetic activity to normal values. In this study, the researchers will test that effect on the total cardiovascular balance.
Conditions
Interventions
- DRUG
-
alpha methyldopa
500 mg twice a day
Sponsors & Collaborators
-
Radboud University Medical Center
lead OTHER
Principal Investigators
-
Ineke Krabbendam, MD · Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Completion
- 2008-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy
NCT00329511 ·Status: WITHDRAWN ·Phase: NA
-
Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial
NCT04835233 ·Status: COMPLETED ·Phase: PHASE4
-
Women Specific Cardiac Recovery After Preeclampsia
NCT02807324 ·Status: UNKNOWN
-
Blood Pressure, Antihypertensive Treatment and Preeclampsia in Pregnant Wom-en With Pre-existing Diabetes
NCT02890836 ·Status: COMPLETED
-
Disease Modification in Toxaemia of Pregnancy
NCT00175695 ·Status: COMPLETED
-
Chronic Hypertension and Pregnancy (CHAP) Project
NCT02299414 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia
NCT00403572 ·Status: COMPLETED
-
Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)
NCT00135707 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiovascular Protection After Preeclampsia With Enalapril
NCT07222852 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Role of Vaspin in Pathophysiology of Pre-eclampsia
NCT06437535 ·Status: NOT_YET_RECRUITING
-
Acute Control of Chronic Hypertension
NCT03877692 ·Status: TERMINATED ·Phase: PHASE4
-
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
NCT06220721 ·Status: RECRUITING ·Phase: NA
-
Treatment Targets for Chronic Hypertension in Pregnancy
NCT00194974 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
NCT02989025 ·Status: RECRUITING ·Phase: PHASE2
-
The ADRB3 Receptor in Pregnancy
NCT02381106 ·Status: SUSPENDED
-
Nicardipine and Labetalol Effects on Cerebral Hemodynamics in Preeclampsia
NCT03761888 ·Status: UNKNOWN
-
Cardiac Output Monitoring to Predict Pre-Eclampsia and Restricted Growth (COMPaRE)
NCT05123677 ·Status: UNKNOWN
-
Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia
NCT05564988 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of Diltiazem for the Control of Blood Pressure in Puerperal Patients With Severe Preeclampsia
NCT04222855 ·Status: COMPLETED ·Phase: NA
-
Peripartum Anesthetic Management of Patients With Preeclampsia
NCT05237011 ·Status: UNKNOWN
-
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia
NCT04063397 ·Status: COMPLETED
-
Left Ventricular and Endothelial Function in Preeclampsia
NCT00201500 ·Status: COMPLETED
-
Phase I Study of Nicotinamide for Early Onset Preeclampsia
NCT02213094 ·Status: COMPLETED ·Phase: PHASE1
-
Cardiovascular Changes in Infants of Preeclampsia Mother
NCT04699825 ·Status: UNKNOWN ·Phase: NA
-
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580 ·Status: COMPLETED ·Phase: EARLY_PHASE1